Predicted upstream regulators that drive the differential expression between APBD subjects and controls, based on IPA analysis, are especially enriched in transcription regulators (e.g., MYC, TP53, XBP1) and several cytokines (Supplementary Table 3). Here, XBP1 is linked to adult polyglucosan body disease.